This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.
For an engineer like Rick, who understood the value of evidence and data, it was a revelation. Most patients say it tastes terrible – imagine the most bitter, plant-like flavor you can think of, and you’re getting close. Not just for Rick, but for all the patients who depended on him? And he never turned anyone away.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. In 2018 there were nearly 24,000 adults arrested for less than 30 grams of cannabis. cannabis arrest data since 2008.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
In nursing school, I wrote my dissertation on the role of the nurse when caring for patients using cannabis therapeutically, knowing that nurses are often the first healthcare professional to whom patients disclose their cannabis use. I remain in awe of these patients to this day.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. Then, in 2017 and 2018, Virginia finally made some moves to establish its own medical marijuana industry. JM Pedini | Photo by Adam Ewing.
Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”
A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients? Although products containing 0.3% A simple question.
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.
A lot of patients ask for Rick Simpson Oil and high-CBD and high-THC hash oil and we cannot give them any credible information about how their cancer will respond to those substances,” Dr. Aguiar said. “But The relief of symptoms can also play a key role in helping cancer patients battle the disease itself. “If
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug. The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018.
Their announcement comes after health officials found the oil in the lungs of 29 patients sickened following their use of portable e-liquid vaporizers. Their reporting indicates that beginning in late 2018, some vendors began to use the oil as an additive in an effort to thicken the consistency of their e-liquids and to mask dilution.
In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% of the patients identified as white, including 96% in Maine.
The Arizona medical marijuana program reached a record breaking high in 2018 with patients consuming nearly 61 tons of cannabis products, according to the Arizona Medical Marijuana Program Report released by the state Department of Health Services on Monday, January 14. pounds being consumed by registered patients.
A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. Cannabis is no longer a one-size-fits-all industry,” Gary Allen, CEO of New Frontier Data, said in a statement.
A new study conducted in Virginia has found that the general public currently consumes more cannabis than cancer patients. The study analyzed data collected between 2013 and 2018, which was a monumental time frame for cannabis legalization and growth of the industry.
Over the first year of adult-use sales , from November 2018 to November 2019, 33 Marijuana Retailers generated $393.7 Since Massachusetts’ first two Marijuana Retailers opened in 2018, 163 more have received notices from the Commission to commence operations statewide and are in the process of opening. Licensing, Agents, and Equity.
They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. As of January, 2021, PTSD was by far the most-listed qualifying condition in the state, with 57,661 out of 107,371 patients.
The study found that medical cannabis use is associated with less frequent hospitalizations among patients living with sickle cell disease (SCD). It’s titled Medical marijuana certification for patients with sickle cell disease: A report of a single center experience. The study was published in the journal Blood Advances.
A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%
In 2018, Amendment 2 was passed, making medical marijuana in the state completely legal. Since these beginnings in 2014, many other changes surrounding the use and possession of medical marijuana have been put into place in Missouri so the state can provide legal medical marijuana to patients suffering from a variety of approved conditions.
In October 2018, I left my position as a Senior Data Scientist at Anne Arundel Medical Center to focus my efforts on Peninsula Alternative Health and our technology and data needs. It’s been an exciting transition ending 2018, and I’m looking forward to what 2019 has to offer.
A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”
This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,
Although medical cannabis has technically been legal in Missouri for over a year and cards have been issued, patients are still waiting desperately for dispensaries to open across the state. On November 8, 2018, Missouri became the 31st state to legalize medical marijuana. million votes. million votes. Randal Williams, et al.
According to a new study published in the journal Pain Management, the presence of THC metabolites in the urine of patients undergoing pain management is associated with lower levels of opioids. The post THC in Urine is Associated with Lower Opioid Concentrations In Pain Patients, Finds Study appeared first on TheJointBlog.
Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues.
The study also found that CBGA interacts with numerous other important receptors in the body like GPR55, TRPV1 channels, as well as GABA receptors, supporting further consideration and research for use in epileptic patients. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.
million euros in tax revenues with medicinal cannabis in 2018. These data are based on an extrapolation of the top pharmacist association. At the end of 2020, cannabis from German cultivation should be available for patients. ( Leafly.de This is what leafly say. million tax revenues through cannabis as medicine. reported. ).
All the data provided by the report are validated and trustworthy and can be used to gain the upper hand in the industry. In a study done in 2018 , when LSD was used alongside psychotherapy, patients experienced greater feelings of empathy, trust, and happiness. Why Is the Psychedelics Market Growing? It was approved by the U.S.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.
The state’s medical patients (about 0.5% The city of Denver, for example, applies an additional 5.5% local sales tax on adult-use cannabis and has collected $210.6 million as of April 2021. Estimated State Tax Revenue from Adult-Use Cannabis 3. 46,104,922. 104,759,961. 167,157,150. 220,688,951. 243,466,892. 279,155,047. 362,027,103.
.” Emerald has four clinics – in Sydney, Melbourne, Perth and the Northern Rivers region of NSW – in which patients can be prescribed medical marijuana under the federal government’s Special Access Scheme.
Two thirds of patients reported improvement in the frequency of seizures (399/622, 64%). There were more reports of improvement from patients treated with CBD-rich extracts (318/447, 71%) than patients treated with purified CBD (81/175, 46%), with statistical significance (p. 12 September 2018. Sec.Neuropharmacology.
A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content